tiprankstipranks
Trending News
More News >
Serina Therapeutics (SER)
:SER
US Market

Serina Therapeutics (SER) Income Statement

Compare
227 Followers

Serina Therapeutics Income Statement

Last quarter (Q3 2025), Serina Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Serina Therapeutics's net income was $-4.58M. See Serina Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 56.00K$ 3.15M$ 500.00K$ 3.04M$ 54.00K
Gross Profit
$ -138.00K$ 3.06M$ 500.00K$ 3.04M$ -1.23M
Operating Expenses
$ 16.91M$ 6.19M$ 2.77M$ 4.67M$ 9.18M
Depreciation and Amortization
$ 194.00K$ 90.00K$ 61.27K$ 33.37K$ 1.25M
EBITDA
$ -10.49M$ 5.92M$ -2.60M$ -1.23M$ -8.74M
Operating Income
$ -17.05M$ -3.13M$ -2.27M$ -1.63M$ -10.41M
Other Income/Expenses
$ 5.84M$ 8.40M$ -411.74K$ 366.81K$ 8.00K
Pretax Income
$ -11.21M$ 5.27M$ -2.68M$ -1.26M$ -10.40M
Net Income
$ -11.14M$ 5.27M$ -2.68M$ -1.26M$ -10.87M
Per Share Metrics
Basic EPS
$ -1.51$ 0.63$ -2.49$ -8.05$ -10.14
Diluted EPS
$ -1.51$ 0.63$ -2.49$ -8.05$ -10.14
Weighted Average Shares Outstanding
7.36M 8.41M 1.08M 1.08M 1.07M
Weighted Average Shares Outstanding (Diluted)
7.36M 8.41M 1.08M 1.08M 1.07M
Currency in USD

Serina Therapeutics Earnings and Revenue History